ExlService Holdings, Inc. Segments Disclosure
| Year ended December 31, 2025 | |||||||||||||||||||||||||||||
| Insurance | Healthcare and Life Sciences | Banking, Capital Markets and Diversified Industries | International Growth Markets | Total | |||||||||||||||||||||||||
| Revenues, net | $ | 710,575 | $ | 532,584 | $ | 482,356 | $ | 362,164 | $ | 2,087,679 | |||||||||||||||||||
Cost of revenues (1) | |||||||||||||||||||||||||||||
| Employee costs | 380,703 | 249,119 | 260,234 | 193,270 | 1,083,326 | ||||||||||||||||||||||||
| Infrastructure and technology costs | 54,310 | 28,943 | 25,952 | 34,002 | 143,207 | ||||||||||||||||||||||||
Other costs (2) | 18,803 | 22,193 | 12,578 | 6,496 | 60,070 | ||||||||||||||||||||||||
Gross profit (1) | $ | 256,759 | $ | 232,329 | $ | 183,592 | $ | 128,396 | $ | 801,076 | |||||||||||||||||||
| Operating expenses | 487,326 | ||||||||||||||||||||||||||||
| Income from operations | 313,750 | ||||||||||||||||||||||||||||
| Foreign exchange gain, net, interest expense and other income, net | 1,302 | ||||||||||||||||||||||||||||
| Income before income tax expense and earnings from equity affiliates | $ | 315,052 | |||||||||||||||||||||||||||
| Year ended December 31, 2024 | |||||||||||||||||||||||||||||
| Insurance | Healthcare and Life Sciences | Banking, Capital Markets and Diversified Industries | International Growth Markets | Total | |||||||||||||||||||||||||
| Revenues, net | $ | 656,419 | $ | 430,679 | $ | 426,716 | $ | 324,558 | $ | 1,838,372 | |||||||||||||||||||
Cost of revenues (1) | |||||||||||||||||||||||||||||
Employee costs (2) | 337,483 | 198,957 | 236,361 | 174,740 | 947,541 | ||||||||||||||||||||||||
| Infrastructure and technology costs | 49,349 | 25,230 | 21,809 | 30,471 | 126,859 | ||||||||||||||||||||||||
Other costs (3) | 38,100 | 18,919 | 10,445 | 5,495 | 72,959 | ||||||||||||||||||||||||
Gross profit (1) | $ | 231,487 | $ | 187,573 | $ | 158,101 | $ | 113,852 | $ | 691,013 | |||||||||||||||||||
| Operating expenses | 427,393 | ||||||||||||||||||||||||||||
| Income from operations | 263,620 | ||||||||||||||||||||||||||||
| Foreign exchange gain, net, interest expense and other income, net | (2,273) | ||||||||||||||||||||||||||||
| Income before income tax expense and earnings from equity affiliates | $ | 261,347 | |||||||||||||||||||||||||||
| Year ended December 31, 2023 | |||||||||||||||||||||||||||||
| Insurance | Healthcare and Life Sciences | Banking, Capital Markets and Diversified Industries | International Growth Markets | Total | |||||||||||||||||||||||||
| Revenues, net | $ | 586,403 | $ | 366,392 | $ | 411,828 | $ | 266,045 | $ | 1,630,668 | |||||||||||||||||||
Cost of revenues (1) | |||||||||||||||||||||||||||||
| Employee costs | 300,249 | 170,675 | 226,576 | 143,462 | 840,962 | ||||||||||||||||||||||||
| Infrastructure and technology costs | 43,289 | 18,924 | 18,860 | 24,400 | 105,473 | ||||||||||||||||||||||||
Other costs (2) | 41,776 | 19,503 | 10,408 | 4,780 | 76,467 | ||||||||||||||||||||||||
Gross profit (1) | $ | 201,089 | $ | 157,290 | $ | 155,984 | $ | 93,403 | $ | 607,766 | |||||||||||||||||||
| Operating expenses | 369,011 | ||||||||||||||||||||||||||||
| Income from operations | 238,755 | ||||||||||||||||||||||||||||
| Foreign exchange gain, net, interest expense and other income, net | (814) | ||||||||||||||||||||||||||||
| Income before income tax expense and earnings from equity affiliates | $ | 237,941 | |||||||||||||||||||||||||||
| Year ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
Data and AI-led (1) | $ | 1,155,342 | $ | 979,731 | $ | 834,737 | |||||||||||
Digital operations (2) | 932,337 | 858,641 | 795,931 | ||||||||||||||
| Revenues, net | $ | 2,087,679 | $ | 1,838,372 | $ | 1,630,668 | |||||||||||
| Year ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Revenues, net | |||||||||||||||||
| North America | $ | 1,725,612 | $ | 1,513,812 | $ | 1,364,449 | |||||||||||
| United Kingdom & Europe | 307,305 | 272,530 | 226,757 | ||||||||||||||
| Rest of World | 54,762 | 52,030 | 39,462 | ||||||||||||||
| Revenues, net | $ | 2,087,679 | $ | 1,838,372 | $ | 1,630,668 | |||||||||||
| Year ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Insurance | $ | 829,899 | $ | 767,311 | $ | 672,869 | |||||||||||
| Healthcare and Life Sciences | 533,542 | 431,790 | 367,340 | ||||||||||||||
| Banking, Capital Markets and Diversified Industries | 724,238 | 639,271 | 590,459 | ||||||||||||||
| Revenues, net | $ | 2,087,679 | $ | 1,838,372 | $ | 1,630,668 | |||||||||||
| As of | |||||||||||
| December 31, 2025 | December 31, 2024 | ||||||||||
| Long-lived assets | |||||||||||
| India | $ | 63,999 | $ | 63,040 | |||||||
| North America | 60,575 | 52,510 | |||||||||
| The Philippines | 36,480 | 25,881 | |||||||||
| South Africa | 19,635 | 23,828 | |||||||||
| Rest of World | 28,543 | 5,362 | |||||||||
| Long-lived assets | $ | 209,232 | $ | 170,621 | |||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 24, 2026 | Showing above |
| 2024 | Feb 25, 2025 | |
| 2023 | Feb 29, 2024 | |
| 2022 | Feb 23, 2023 | |
| 2021 | Feb 24, 2022 | |
| 2020 | Feb 25, 2021 | |
| 2019 | Feb 27, 2020 | |
| 2018 | Feb 28, 2019 | |
| 2017 | Feb 27, 2018 | |
| 2016 | Mar 15, 2017 | |
| 2015 | Feb 26, 2016 | |
About Segments Disclosures
Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.
Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.